Gene · 90
Papers2,859
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
901 to 920 of 2,859
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Inhibiting Endothelial Cell Function in Normal and Tumor Angiogenesis Using BMP Type I Receptor Macrocyclic Kinase Inhibitors. | Cancers (Basel) | 2021 | 34204675 | PubTator, text mining | PubMed |
| The Role of lncRNAs in the Stem Phenotype of Pancreatic Ductal Adenocarcinoma. | Int J Mol Sci | 2021 | 34203589 | PubTator, text mining | PubMed |
| Postnatal Expression Profile of MicroRNAs Associated with Cardiovascular Diseases in 3- to 11-Year-Old Preterm-Born Children. | Biomedicines | 2021 | 34202871 | PubTator, text mining | PubMed |
| Peptides Derived from Growth Factors to Treat Alzheimer's Disease. | Int J Mol Sci | 2021 | 34199883 | PubTator, text mining | PubMed |
| The BMP Pathway in Blood Vessel and Lymphatic Vessel Biology. | Int J Mol Sci | 2021 | 34198654 | PubTator, text mining | PubMed |
| Generation of an induced pluripotent stem cell line (TRNDi031-A) from a patient with Alagille syndrome type 1 carrying a heterozygous p. C312X (c. 936 T > A) mutation in JAGGED-1. | Stem Cell Res | 2021 | 34198154 | PubTator, text mining | PubMed |
| The BMP antagonist gremlin 1 contributes to the development of cortical excitatory neurons, motor balance and fear responses. | Development | 2021 | 34184027 | PubTator, text mining | PubMed |
| A Decade of JAK Inhibitors: What Have We Learned and What May Be the Future? | Arthritis Rheumatol | 2021 | 34180156 | PubTator, text mining | PubMed |
| Bone Homeostasis and Gut Microbial-Dependent Signaling Pathways. | J Microbiol Biotechnol | 2021 | 34176870 | PubTator, text mining | PubMed |
| Droplet digital PCR-based detection of circulating tumor DNA from pediatric high grade and diffuse midline glioma patients. | Neurooncol Adv | 2021 | 34169282 | PubTator, text mining | PubMed |
| Intracerebral administration of CTLA-4 and PD-1 immune checkpoint blocking monoclonal antibodies in patients with recurrent glioblastoma: a phase I clinical trial. | J Immunother Cancer | 2021 | 34168003 | PubTator, text mining | PubMed |
| Integrating Transcriptome-Wide Association Study and mRNA Expression Profiling Identifies Novel Genes Associated With Osteonecrosis of the Femoral Head. | Front Genet | 2021 | 34163523 | PubTator, text mining | PubMed |
| A self-amplifying loop of YAP and SHH drives formation and expansion of heterotopic ossification. | Sci Transl Med | 2021 | 34162750 | PubTator, text mining | PubMed |
| Iron overload inhibits BMP/SMAD and IL-6/STAT3 signaling to hepcidin in cultured hepatocytes. | PLoS One | 2021 | 34161397 | PubTator, text mining | PubMed |
| Analysis of exosome-derived microRNAs reveals insights of intercellular communication during invasion of breast, prostate and glioblastoma cancer cells. | Cell Adh Migr | 2021 | 34157951 | PubTator, text mining | PubMed |
| Current knowledge on the immune microenvironment and emerging immunotherapies in diffuse midline glioma. | EBioMedicine | 2021 | 34157482 | PubTator, text mining | PubMed |
| Structure of AMH bound to AMHR2 provides insight into a unique signaling pair in the TGF-β family. | Proc Natl Acad Sci U S A | 2021 | 34155118 | PubTator, text mining | PubMed |
| Macrophages Derived From Human Induced Pluripotent Stem Cells: The Diversity of Protocols, Future Prospects, and Outstanding Questions. | Front Cell Dev Biol | 2021 | 34150747 | PubTator, text mining | PubMed |
| Generation of an induced pluripotent stem cell line (TRNDi012-B) from Fibrodysplasia Ossificans Progressiva (FOP) patient carrying a heterozygous mutation c. 617G > A in the ACVR1 gene. | Stem Cell Res | 2021 | 34139597 | PubTator, text mining | PubMed |
| Therapeutic and diagnostic targeting of fibrosis in metabolic, proliferative and viral disorders. | Adv Drug Deliv Rev | 2021 | 34139255 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/90/papers?page=46